Cancer

Beyond Medals: The Toughest Discipline is Overcoming Daily Disability Barriers

Ottobock Launches Paralympic Games Initiative: ‘The Unofficial Discipline'BURLINGTON, ON / ACCESSWIRE / August 26, 2024 / As the world gathers…

1 year ago

MIRA Pharmaceuticals Achieves 100% Reversal of Neuropathic Pain With Oral Ketamir-2 in Breakthrough Study

Study Highlights Superior Efficacy of Ketamir-2 Over Oral Ketamine, Achieving Full Normalization of Pain ThresholdsMIAMI, FL / ACCESSWIRE / August…

1 year ago

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

FORT LAUDERDALE, FL / ACCESSWIRE / August 26, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering…

1 year ago

First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company

PASADENA, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”),…

1 year ago

Laboratory Informatics Market worth $8.7 billion by 2029 driven by Emerging Tech Innovations | MarketsandMarkets™

CHICAGO, Aug. 23, 2024 /PRNewswire/ -- The global Laboratory Informatics Market is valued at an estimated USD 5.3 billion in…

1 year ago

Ablation Technology Market worth $9.62 billion by 2029 driven by Emerging Tech Innovations | MarketsandMarkets™

CHICAGO, Aug. 23, 2024 /PRNewswire/ -- The global Ablation Technology Market is valued at an estimated USD 6.11 billion in…

1 year ago

Izotropic Announces Regulatory Approval Plans to Launch Izoview for Breast Cancer Diagnostics in Patients with Dense Breasts in the U.S. and EU

Vancouver, British Columbia--(Newsfile Corp. - August 23, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device…

1 year ago

European Commission approves BALVERSA®▼ (erdafitinib) for adult patients with unresectable or metastatic urothelial carcinoma

First pan FGFR kinase inhibitor to be approved in the European Economic Area, for adults with unresectable or metastatic urothelial…

1 year ago

AI Impact on Radiation Detection And Monitoring Equipment Market growth, set to increase by USD 1.59 billion from 2024-2028, Demand from healthcare facilities to boost the revenue, Technavio

NEW YORK, Aug. 22, 2024 /PRNewswire/ -- The global radiation detection and monitoring equipment market  size is estimated to grow…

1 year ago

Openwater Achieves Quantum Leap in Medicine: Harnesses Light, Sound, and Electromagnetics to Diagnose and Treat Diseases at Cellular Level

Company Announces $100 Million in Total Funding from New and Existing Investors to Advance Medical InnovationNEWARK, Calif.--(BUSINESS WIRE)--Openwater today announced…

1 year ago